Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views
Last Hour:
Last 24 Hours:

ChemioCare planning to IPO and raise funds to bring 'transformative' drug to the market

% of readers think this story is Fact. Add your two cents.

ChemioCare CEO Pedro Lichtinger tells Proactive Investors the bio-pharmaceutical company is focused on treating the side effects of chemotherapy.

Founded around one year ago, Lichtinger says the company’s transdermal patch technology will help cancer patients going through chemotherapy to experience significantly less side effects of the drug including less nausea and vomiting.

Lichtinger says the company is planning to go public and list on the Nasdaq and the TSX in around 10 months, using the capital raised to run the clinical trials for the drug.

Story by ProactiveInvestors

Report abuse


    Your Comments
    Question Razz Sad Evil Exclaim Smile Redface Biggrin Surprised Eek Confused Cool LOL Mad Twisted Rolleyes Wink Idea Arrow Neutral Cry Mr. Green




    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.